In 2005, Nexa acquired the pyrocarbon-based upper extremity implant family from French firm BioProfile, making Nexa the only fully integrated provider of pyrocarbon implants to the orthopedic community. Our proprietary method of pyrocarbon and metal mating — a ground-breaking feature never before possible with pyrocarbon implants — provides optimal articulation combined with proven implant fixation. This innovative technology supports our intention to advance the applications of pyrocarbon in orthopedics.
Pyrocarbon has gained widespread acceptance for use in heart valves due to its total biocompatibility, an extremely low friction coefficient, and a high resistance to wear. The material also has an elasticity quite similar to bone, which makes it an ideal material for upper extremity implants.
On May 19, 2006, Nexa received FDA approval for its first pyrocarbon implant. Read the announcement here and contact us to learn more about availability of the CMI and upcoming Nexa pyrocarbon implants.
|
